Select Your Region
Global
Search results
Review the results we have found for you.
Use the filters to narrow down the results list and easily find the trial you look for.
Refine your search
Search
Metabolic Disorder
Location
Please note that the recruitment status of the study at your site may differ from the overall study status because some study sites may recruit earlier than others.
We could not find any results for 'METABOLIC DISORDER'. Below you can find all 59 available trials.
Change search criteria or use the filters to narrow down your search.
1 
Study StatusActive, not recruiting1 A clinical trial to compare GDC-9545 with a doctor’s choice of hormonal therapy in people with advanced or metastatic breast cancer after previous treatment has not worked.
A Study Evaluating the Efficacy and Safety of GDC-9545 Compared With Physician's Choice of Endocrine Monotherapy in Participants With Previously Treated Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer
- Cancer,
- Breast Cancer,
- Breast Cancer Er-Positive,
- Breast Cancer HER-2 Negative,
- Locally Advanced or Metastatic Breast Cancer,
- Estrogen Receptor (ER)-Positive
- NCT04576455, WO42312, 2020-001984-10
2 Study StatusActive, not recruiting2 A study to look at how safe emicizumab treatment is and how well it works to prevent bleeds in children with haemophilia A (without factor 8 inhibitors) who started emicizumab in their first year of life
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Subcutaneous Emicizumab in Participants From Birth to 12 Months of Age With Hemophilia A Without Inhibitors
- Hemophilia,
- Hemophilia A,
- Severe Hemophilia A
- NCT04431726, MO41787, 2020-001733-12,2023-505964-13-00
3 Study StatusActive, not recruiting3 A clinical trial to compare tiragolumab plus atezolizumab and bevacizumab with placebo plus atezolizumab and bevacizumab in people with untreated, advanced hepatocellular carcinoma
A Study Evaluating Atezolizumab and Bevacizumab, With or Without Tiragolumab, in Participants With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma (IMbrave152)
- Cancer,
- Hepatocellular Carcinoma (HCC)
- NCT05904886, CO44668, 2023-503422-39-00
4 Study StatusActive, not recruiting4 A study to look at the effects of different treatments on rare types of previously treated epithelial ovarian, fallopian tube or primary peritoneal cancers with different molecular changes
A Study Evaluating the Efficacy and Safety of Biomarker-Driven Therapies in Patients With Persistent or Recurrent Rare Epithelial Ovarian Tumors
- Cancer,
- Ovarian Cancer
- NCT04931342, WO42178, GOG-3051, ENGOT-GYN2
5 Study StatusActive, not recruiting5 A study evaluating the efficacy and safety of neoadjuvant treatment with atezolizumab or placebo in combination with platinum-based chemotherapy in patients with resectable stage II, IIIA, or select IIIB non-small cell lung cancer
A Study of Neoadjuvant Atezolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Patients With Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (IMpower030)
- Cancer,
- Lung Cancer,
- Non-Small Cell Lung Cancer (NSCLC)
- NCT03456063, GO40241, 2023-504209-35-00
6 Study StatusActive, not recruiting6 A clinical trial to look at how well obinutuzumab works in treating people with lupus nephritis and how safe it is (REGENCY)
A Study To Evaluate The Efficacy And Safety Of Obinutuzumab In Patients With ISN/RPS 2003 Class III Or IV Lupus Nephritis
- Autoimmune Disorder,
- Lupus Nephritis
- NCT04221477, CA41705, 2019-004034-42
7 Study StatusActive, not recruiting7 A clinical trial to compare tobemstomig with pembrolizumab in combination with nab-paclitaxel in people with untreated breast cancer
A Study of Tobemstomig + Nab-Paclitaxel Compared With Pembrolizumab + Nab-Paclitaxel in Participants With Previously Untreated, PD-L1-Positive, Locally-Advanced Unresectable or Metastatic Triple-Negative Breast Cancer
- Cancer,
- Breast Cancer,
- Triple Negative Breast Cancer
- NCT05852691, CO44194, 2022-502457-34-00
8 Study StatusActive, not recruiting8 A clinical trial to look at how safe emicizumab is in patients with mild or moderate hemophilia A, and how emicizumab affects bleeding in this patient population.
A Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Emicizumab in Participants With Mild or Moderate Hemophilia A Without FVIII Inhibitors
- Hemophilia,
- Hemophilia A
- NCT04158648, BO41423, 2023-506610-52-00
9 Study StatusActive, not recruiting9 A Study Evaluating the Efficacy and Safety of Giredestrant Plus Everolimus Compared With the Physician's Choice of Endocrine Therapy Plus Everolimus in Participants With Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer (evERA Breast Cancer)
- Cancer,
- Breast Cancer,
- Breast Cancer Er-Positive,
- Breast Cancer HER-2 Negative,
- Locally Advanced or Metastatic Breast Cancer,
- Estrogen Receptor (ER)-Positive
- NCT05306340, ML43171, 2022-000199-20,2023-506821-12-00
10 Study StatusActive, not recruiting10 A clinical trial to compare inavolisib plus fulvestrant versus alpelisib plus fulvestrant in people with hormone receptor-positive, HER2-negative, PIK3CA-mutated breast cancer that has spread during or after treatment with a CDK4/6 inhibitor plus hormone (endocrine) therapy
A Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or Metastatic Breast Cancer Post CDK4/6i and Endocrine Combination Therapy
- Cancer,
- Breast Cancer,
- Breast Cancer Er-Positive,
- Breast Cancer HER-2 Negative
- NCT05646862, WO43919, 2022-502322-41-00